Acción LABP LANDOS BIOPHARMA, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Landos Biopharma, Inc.

Acciones

LABP

US5150692011

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:30:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
22,3 USD -0,80 % Gráfico intradía de Landos Biopharma, Inc. +0,68 % +509,29 %
01/04 LANDOS BIOPHARMA, INC. : Pasa de una recomendación de Compra a Neutral por HC Wainwright ZM
25/03 Operaciones del día-Fusiones y adquisiciones RE

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
North American Morning Briefing : Stocks Seen -2-
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
Deals of the day-Mergers and acquisitions
Sector Update: Health Care Stocks Decline Late Afternoon
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE
Top Midday Gainers
Sector Update: Health Care Stocks Softer in Afternoon Trading
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders
AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie
AbbVie in Deal to Acquire Landos Biopharma for $137.5 Million
AbbVie to Acquire Landos Biopharma for About $137.5 Million
AbbVie to Acquire Landos Biopharma for About $137.5 Million
AbbVie to buy Landos to expand pipeline of immunity-related illnesses
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
AbbVie Inc. agreed to acquire Landos Biopharma, Inc. on March 24, 2024.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción LABP
  4. Noticias Landos Biopharma, Inc.
  5. Otros idiomas